Back to top

GH Maintains Rating by Guggenheim -- Price Target Raised to $190

GH Maintains Rating by Guggenheim -- Price Target Raised to $190

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Guardant Health, Inc. (GH)